English

Anacor Pharmaceuticals, Inc.

EDGAR

Quarterly report (10-Q) · filed 2016-05-10

27 filing records in this dataset, filed from 2010-09-10 to 2016-05-10. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

12.6 million USD

2011-09-30 · USD

Exact inputs and evidence

Revenue: 12644000 USD Source

Operating margin

-32.2%

2011-09-30 · %

Exact inputs and evidence

Operating Income: -4072000 USD Source
Revenue: 12644000 USD Source

Operating cash flow

-7.57 million USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -23381000 USD Source
Operating Cash Flow: -15808000 USD Source

Free cash flow

-7.7 million USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -23381000 USD Source
Operating Cash Flow: -15808000 USD Source
Capital Expenditure: 476000 USD Source
Capital Expenditure: 351000 USD Source

Cash and cash equivalents: 17.3 million USD 2011-09-30 Source
Exact value

17299000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-05-10.

Financial data available through: 2010-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2010-12-31
Operating income: 3 of 11 periods available· newest 2010-12-31
Net income: 3 of 11 periods available· newest 2010-12-31
Operating cash flow: 3 of 11 periods available· newest 2010-12-31
Capital expenditure: 3 of 11 periods available· newest 2010-12-31
Total assets: 2 of 11 periods available· newest 2010-12-31
liabilities: No compatible figures in this window
Current assets: 2 of 11 periods available· newest 2010-12-31
Current liabilities: 2 of 11 periods available· newest 2010-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2010-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+49.2%

Prior period

USD 18.64 million

2009-01-01 – 2009-12-31
Current period

USD 27.82 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

27824000 − 18643000 = 9181000 USD

18643000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
27824000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Anacor Pharmaceuticals, Inc. · 2010-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Year-over-year change in Revenue: 9181000 USD Concept: fundies:Revenue Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 27824000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#8101 Input fundies:Revenue: 18643000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#8101
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 14.78 million

Prior period

−USD 24.84 million

2009-01-01 – 2009-12-31
Current period

−USD 10.06 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

-10058000 − -24839000 = 14781000 USD

-24839000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
-10058000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Anacor Pharmaceuticals, Inc. · 2010-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Year-over-year change in Net income: 14781000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -10058000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#9970 Input fundies:NetIncome: -24839000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#9970
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 24.64 million

Prior period

−USD 27.82 million

2009-01-01 – 2009-12-31
Current period

−USD 3.18 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

-3182000 − -27824000 = 24642000 USD

-27824000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
-3182000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Anacor Pharmaceuticals, Inc. · 2010-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Year-over-year change in Operating cash flow: 24642000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -3182000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10268 Input fundies:OperatingCashFlow: -27824000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10268
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-47%

Prior period

USD 202,000

2009-01-01 – 2009-12-31
Current period

USD 107,000

2010-01-01 – 2010-12-31

Exact inputs and evidence

107000 − 202000 = -95000 USD

202000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
107000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Anacor Pharmaceuticals, Inc. · 2010-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Year-over-year change in Capital expenditure: -95000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 107000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10333 Input fundies:CapitalExpenditure: 202000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10333
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2010-01-01 – 2010-12-31

Revenue USD 27.82 million 100% of revenue
Operating costs Derived USD 37.32 million 134% of revenue
Operating income −USD 9.49 million −34% of revenue
Tax, interest and other Derived USD 564,000 2% of revenue
Net income −USD 10.06 million −36% of revenue

Cash

Operating cash flow −USD 3.18 million −11% of revenue
Capital expenditure USD 107,000 0.4% of revenue
Free cash flow Derived −USD 3.29 million −12% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 Operating loss: operating costs were 185% of revenue.
2009 Operating loss: operating costs were 221% of revenue.
2010 Operating loss: operating costs were 134% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2008-01-01 – 2008-12-31	25076000	46360000 Derived	-21284000	341000 Derived	-21625000	-41516000 Derived	Source 2008-01-01 – 2008-12-31: 25076000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -21284000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -21625000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -39390000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 2126000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	18643000	41137000 Derived	-22494000	2345000 Derived	-24839000	-28026000 Derived	Source 2009-01-01 – 2009-12-31: 18643000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -22494000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -24839000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -27824000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 202000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	27824000	37318000 Derived	-9494000	564000 Derived	-10058000	-3289000 Derived	Source 2010-01-01 – 2010-12-31: 27824000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -9494000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -10058000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -3182000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 107000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 27.8M 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Revenue	25076000	Revenue: 25076000 Open source
20092009-12-31	Revenue	18643000	Revenue: 18643000 Open source
20102010-12-31	Revenue	27824000	Revenue: 27824000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

49.2% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Year over year	No prior comparable period	Revenue: 25076000 Open source
20092009-12-31	Year over year	-25.7%	Revenue: 18643000 Open source Revenue: 25076000 Open source
20102010-12-31	Year over year	49.2%	Revenue: 27824000 Open source Revenue: 18643000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -34.1% 2010

Net margin -36.1% 2010

Free cash flow margin -11.8% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Operating margin	-84.9%	Operating Income: -21284000 Open source Revenue: 25076000 Open source
20092009-12-31	Operating margin	-120.7%	Operating Income: -22494000 Open source Revenue: 18643000 Open source
20102010-12-31	Operating margin	-34.1%	Operating Income: -9494000 Open source Revenue: 27824000 Open source
20082008-12-31	Net margin	-86.2%	Net Income: -21625000 Open source Revenue: 25076000 Open source
20092009-12-31	Net margin	-133.2%	Net Income: -24839000 Open source Revenue: 18643000 Open source
20102010-12-31	Net margin	-36.1%	Net Income: -10058000 Open source Revenue: 27824000 Open source
20082008-12-31	Free cash flow margin	-165.6%	Revenue: 25076000 Open source Operating Cash Flow: -39390000 Open source Capital Expenditure: 2126000 Open source
20092009-12-31	Free cash flow margin	-150.3%	Revenue: 18643000 Open source Operating Cash Flow: -27824000 Open source Capital Expenditure: 202000 Open source
20102010-12-31	Free cash flow margin	-11.8%	Revenue: 27824000 Open source Operating Cash Flow: -3182000 Open source Capital Expenditure: 107000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -3.2M 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Operating cash flow	-39390000	Operating Cash Flow: -39390000 Open source
20092009-12-31	Operating cash flow	-27824000	Operating Cash Flow: -27824000 Open source
20102010-12-31	Operating cash flow	-3182000	Operating Cash Flow: -3182000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -3.3M 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Free cash flow	-41516000	Operating Cash Flow: -39390000 Open source Capital Expenditure: 2126000 Open source
20092009-12-31	Free cash flow	-28026000	Operating Cash Flow: -27824000 Open source Capital Expenditure: 202000 Open source
20102010-12-31	Free cash flow	-3289000	Operating Cash Flow: -3182000 Open source Capital Expenditure: 107000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2008-12-31	Liabilities / assets	Not reported	No source recorded
2009-12-31	Liabilities / assets	Not reported	Total Assets: 17945000 Open source
2010-12-31	Liabilities / assets	Not reported	Total Assets: 83964000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.56× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2008-12-31	Current assets / current liabilities	Not reported	No source recorded
20092009-12-31	Current assets / current liabilities	1.31×	Current Assets: 15196000 Open source Current Liabilities: 11563000 Open source
20102010-12-31	Current assets / current liabilities	5.56×	Current Assets: 81320000 Open source Current Liabilities: 14633000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2008 2008-01-01 – 2008-12-31	−USD 21.63 million Exact value Exact value: -21625000 USD 2008-01-01 – 2008-12-31: -21625000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Anacor Pharmaceuticals, Inc. · 2008-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Net Income: -21625000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21625000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#9970 The citation records this snapshot. The page link may show a newer release later.	−USD 39.39 million Exact value Exact value: -39390000 USD 2008-01-01 – 2008-12-31: -39390000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Anacor Pharmaceuticals, Inc. · 2008-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Operating Cash Flow: -39390000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -39390000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10268 The citation records this snapshot. The page link may show a newer release later.	USD 2.13 million Exact value Exact value: 2126000 USD 2008-01-01 – 2008-12-31: 2126000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Anacor Pharmaceuticals, Inc. · 2008-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Capital Expenditure: 2126000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2126000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10333 The citation records this snapshot. The page link may show a newer release later.	−USD 41.52 million Calculation and evidence -39390000 − 2126000 USD Exact free cash flow: -41516000 USD 2008-01-01 – 2008-12-31: -39390000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 2126000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Anacor Pharmaceuticals, Inc. · 2008-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Free cash flow: -41516000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -39390000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10268 Input fundies:CapitalExpenditure: 2126000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10333 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 24.84 million Exact value Exact value: -24839000 USD 2009-01-01 – 2009-12-31: -24839000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Anacor Pharmaceuticals, Inc. · 2009-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Net Income: -24839000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24839000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#9970 The citation records this snapshot. The page link may show a newer release later.	−USD 27.82 million Exact value Exact value: -27824000 USD 2009-01-01 – 2009-12-31: -27824000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Anacor Pharmaceuticals, Inc. · 2009-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Operating Cash Flow: -27824000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27824000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10268 The citation records this snapshot. The page link may show a newer release later.	USD 202,000 Exact value Exact value: 202000 USD 2009-01-01 – 2009-12-31: 202000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Anacor Pharmaceuticals, Inc. · 2009-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Capital Expenditure: 202000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 202000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10333 The citation records this snapshot. The page link may show a newer release later.	−USD 28.03 million Calculation and evidence -27824000 − 202000 USD Exact free cash flow: -28026000 USD 2009-01-01 – 2009-12-31: -27824000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 202000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Anacor Pharmaceuticals, Inc. · 2009-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Free cash flow: -28026000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27824000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10268 Input fundies:CapitalExpenditure: 202000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10333 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 10.06 million Exact value Exact value: -10058000 USD 2010-01-01 – 2010-12-31: -10058000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Anacor Pharmaceuticals, Inc. · 2010-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Net Income: -10058000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10058000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#9970 The citation records this snapshot. The page link may show a newer release later.	−USD 3.18 million Exact value Exact value: -3182000 USD 2010-01-01 – 2010-12-31: -3182000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Anacor Pharmaceuticals, Inc. · 2010-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Operating Cash Flow: -3182000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3182000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10268 The citation records this snapshot. The page link may show a newer release later.	USD 107,000 Exact value Exact value: 107000 USD 2010-01-01 – 2010-12-31: 107000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Anacor Pharmaceuticals, Inc. · 2010-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Capital Expenditure: 107000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 107000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10333 The citation records this snapshot. The page link may show a newer release later.	−USD 3.29 million Calculation and evidence -3182000 − 107000 USD Exact free cash flow: -3289000 USD 2010-01-01 – 2010-12-31: -3182000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 107000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Anacor Pharmaceuticals, Inc. · 2010-12-31 Anacor Pharmaceuticals, Inc. (edgar:1411158) Free cash flow: -3289000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:17:12Z Snapshot: 779a8f7ab60e9743ba48b56423949d9e020556eab134162376e1782c3b1fdf77 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1411158?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3182000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10268 Input fundies:CapitalExpenditure: 107000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1411158/0001047469-11-002828.txt#10333 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

27 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001411158, 1411158, edgar:1411158

Also known as Anacor Pharmaceuticals Inc

Anacor Pharmaceuticals, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2010 2010-01-01 – 2010-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation